Advancing Eyecare™ Alliance.  Learn More
Advancing Eyecare™ Alliance. Learn More

Clinical Case Report: Treatment of Central Serous Chorioretinopathy – from LIGHTMED

Brought to you by Lightmed

Lightmed’s clinical team shares this educational case report, including success stories from patients.

Click here to read the full report.

Key Points:

  • The LIGHTMED TruScan 577nm with SP-Mode® Microsecond Laser Technology is a safe and effective technology to treat central serous retinopathy.

  • Early diagnosis and treatment is important in CSC in order to reduce the duration of SRD, and avoid degeneration of the RPE.

  • SP-Mode® Microsecond Laser Technology is used in the treatment of warming RPE cells, in order to lead to the “functional remodeling” of the RPE and the subsequent improvement of retinal function.

  • The yellow wavelength is well absorbed by the RPE melanin; and thus, it is suitable to treat RPE cells efficiently.

  • Test irradiation is important for every patient because each person has a different extent of light absorption. Half of the visible threshold is a safe and effective parameter to treat CSC without scar formations.

  • SRF reduction varies among patients, and it is important to wait at least 3 months after treatment to notice SRF reduction.

Click the image to read the full Clinical Case Report

Free shipping is only available for online orders in the continental United States.
Certain exclusions apply. 

Exclusions include, but are not limited, to the following products:

Acuity Systems & Projectors, Chair & Stand Accessories, Autorefractors, Lensmeters, Keratometers, Portable Slit Lamps, Stools, Tables, Tonometers, Trial Lens Sets.